Corrigendum to "Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - How much is enough?" [Exp. Neurol. 248 (2013) 30-44]

Brian K. Kwon, Lesley J.J. Soril, Mark Bacon, Michael S. Beattie, Armin Blesch, Jacqueline C. Bresnahan, Mary Bartlett Bunge, Sarah A. Dunlop, Michael G. Fehlings, Adam R. Ferguson, Caitlin E. Hill, Soheila Karimi-Abdolrezaee, Paul Lu, John W. McDonald, Hans W. Müller, Martin Oudega, Ephron S. Rosenzweig, Paul J. Reier, Jerry Silver, Eva SykovaXiao Ming Xu, James D. Guest, Wolfram Tetzlaff

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)299-300
Number of pages2
JournalExperimental Neurology
Volume248
DOIs
StatePublished - Oct 1 2013

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Kwon, B. K., Soril, L. J. J., Bacon, M., Beattie, M. S., Blesch, A., Bresnahan, J. C., Bunge, M. B., Dunlop, S. A., Fehlings, M. G., Ferguson, A. R., Hill, C. E., Karimi-Abdolrezaee, S., Lu, P., McDonald, J. W., Müller, H. W., Oudega, M., Rosenzweig, E. S., Reier, P. J., Silver, J., ... Tetzlaff, W. (2013). Corrigendum to "Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - How much is enough?" [Exp. Neurol. 248 (2013) 30-44]. Experimental Neurology, 248, 299-300. https://doi.org/10.1016/j.expneurol.2013.07.001